Publications by authors named "Ola Falk"

Claim this Profile
A
A 30-minute intravenous infusion of rituximab is safe and cost-effective (SpeedR).
Björn Engelbrekt Wahlin, Maria Ljungqvist, Ola Falk, Therese Rådman, Sandra Lindé

Ann Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis